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Abstract
Brugia infections occur via the bite of an infected mosquito. Third stage infective larvae
(L3) deposited on the skin during feeding migrate into the bite wound, through skin and
into the lymphatic system. It is hypothesized that L3 excretory/secretory products (ES)
are important in this initial phase of the infection. A model for these early migrations has
been established by inoculating L3s into the dermis (ID) of the permissive gerbil host. In
this model, most L3s injected ID in the louer hind limb travel to the popliteal lymph node
by 3 days post infection. Adult parasites are located primarily in the spermatic cord
lymphatics by 28 days post infection. L3s injected into the peritoneal cavity (IP) do not
migrate, thus ES may play a different role in these infections. Knowledge is lacking on
the role of L3 ES in B. pahangi migration and establishment. Proteins in 24 hour L3 ES
may facilitate early L3 migration and antibodies to ES may inhibit migration and/or
worm establishment. Migration inhibition was assayed in vivo by immunizing gerbils
with either 24 hour L3 ES in RIBI adjuvant or RIBI alone. Gerbils were subsequently
challenged either ID or IP with 100 L3s and euthanized at 3 and 106 days post infection.
Western blot analysis indicates that antibodies in prechallenge sera are produced against
ES and share homology with antigens in other B. pahangi stages. ES immunization
increased L3 recovery in both ID and IP infected animals at 3DPI. No difference was
noted at 106DPI. ES immunization also reduced L3 migration in ID infected gerbils at
3DPI. At 106DPI, immunized animals showed fewer circulating microfilaria and
intralymphatic thrombi. At 3DPI, the increase in worm recoveries following
immunization may be associated with a decrease in larval migration. The results also
suggest that antibody to ES is insufficient to provide protection at both 3DPI and 106DPI.
iv

Nonetheless, this response appears to limit the fecundity of adult worms and subsequent
formation of intralymphatic thrombi.

v

Chapter 1: General Introduction
Lymphatic filariasis (LF) affects approximately 128 million people in mainly tropical
and subtropical regions of the world and is caused by the lymphatic dwelling filarial
nematodes Brugia malayi, B. timori, and Wuchereria bancrofti (Scott, 2000). According
to the Global Alliance to Eliminate Lymphatic Filariasis (GELF), a partnership and
control program created to raise political, financial, and technical support for LF, more
than 1 billion people in approximately 80 countries are at risk of contracting LF. One
way GELF provides support is by distributing anti-filarial medications (albendazole and
ivermectin or albendazole and diethylcarbamizine). This chemotherapy restores filarial
antigen-specific immune responsiveness which is usually downregulated during infection
(Michael, 2002). In addition, the medications also kill microfilariae, the sheathed
offspring produced by adult female worms. This is vital to preventing transmission,
which is dependent on the ingestion of microfilariae by mosquito vectors during feeding.
The chemotherapy has been successful in some areas but minimal in others because of
compliance issues in endemic communities. Everyone in an area should be treated
multiple times for transmission inhibition to be effective (Kazura, 2002). GELF also
provides support by educating infected patients on hygiene practices benificial to chronic
filariasis. For example, washing the feet of infected people minimize secondary bacterial
infections and decrease lymphedema by promoting lymph flow.
LF can present as a broad spectra of disease manifestations. These manifestations
may be related to the different immune responses of infected individuals (Nutman, 1995).
The establishment of distinct categories of this clinical spectrum was needed to compare
the manifestations of disease with immunological and other physiologic measurements.
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In regions with endemic LF, infections are divided into three groups. Most individuals
are microfilaremic and asymptomatic. They are typically hyporesponsive to filarial
antigens and serve as a reservoir for continued transmission of lymphatic dwelling filaria.
Another group of infected individuals exhibit hyperresponsiveness to filarial antigens and
show symptoms and pathology associated with infection such as elephantiasis,
adenolymphangitis, and tropical pulmonary eosinophilia (TPE). These individuals
exhibit acute and/or chronic lymphatic pathology. Acute disease is characterized by
adenolymphangitis and episodic fevers. Chronic disease is associated with elephantiasis,
lymphatic obstruction, and lymphedema (Kumaraswami, 2000). These individuals are
typically free from circulating microfilariae (Nutman, 1995). A third group includes
patients with occult infections that are asymptomatic and amicrofilaremic. These
individuals, termed “endemic normals” (EN) or “putatively immune” (PI), are either
immune to infection or are not sufficiently exposed to the parasite to become infected.
The life cycles of filarial nematodes require two hosts: an arthropod intermediate host
which serves as the vector and a terrestrial vertebrate as a final host (Bain and Babayan,
2003). Initial entry into a host is preceded by trauma to the epithelium made by an agent
other than the parasite (Lewert, 1958). In humans, mosquito-derived B. malayi infective
third stage larvae (L3s) are deposited onto skin in mosquito hemolymph during feeding
(Ewert and Ho, 1967). Tissue migration is required before establishment in the definitive
host can occur. It has been suggested that the larvae secrete proteases and other enzymes
such as elastases and collagenases, allowing penetration through local connective tissue
into the lymphatics (Scott, 2000). Nine to fourteen days post infection (DPI), the molt
from the L3 to fourth stage larvae (L4) occurs (Scott, 2000). The L4s then molt to
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become immature adult parasites. Mature adults mate and females produce microfilariae,
which travel to the bloodstream and can be ingested by a feeding mosquito. These
microfilariae enter the midgut of the mosquito (Bartholomay and Christensen, 2002).
Those that escape mosquito defenses exsheath within a few hours and migrate to the
thoracic flight musculature where they further develop to the first larval stage (L1). L1s
molt to the second stage larvae (L2) followed by a subsequent molt to the infective L3
stage. Ten to fifteen days after microfilarial ingestion, L3s migrate through the hemocoel
to the proboscis tip where they are transmitted to a host upon feeding of the mosquito
(Bartholomay and Christensen, 2002). During this process, the L3s are deposited onto
the skin in a drop of hemolymph. The larvae then migrate presumably into the bite
wound created by the mosquito (Ewert, 1967).
As previously stated, during this life cycle, it has been hypothesized that biologically
active molecules produced and secreted by the parasite facilitate tissue penetration.
These molecules are hypothesized to be in the excretory and secretory products (ES) of
the larvae. Adult parasite ES has been well studied in nematodes, including filariae
(Kaushal et. al., 1982; Allen and McDonald, 1998; (Tezuka et al., 2003). Information
regarding ES from larval stages of filaria is lacking due to difficulty in obtaining
sufficient parasite material (Yenbutr and Scott, 1995). Multiple functions for larval and
adult nematode ES have been suggested, including parasite migration in the host (Tsuji et
al., 2003; Tsuji et al., 2004) parasite establishment (Sen et al., 2000) and host
immunomodulation (Harnett et al., 1999b; Gomez-Escobar et al., 2005) including
macrophage and granulocyte function modification (Lightowlers and Rickard, 1988),
suppression of B and T cell proliferation (Harnett and Harnett, 1993; Hartmann et al.,
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1997; Harnett and Harnett, 1999) and surface-bound antibody shedding (Selkirk et al.,
1993). In addition, immunity to ES products have been suggested to be involved in
immunopathology and host protection (Maizels et al., 1999).
Two of the few studies aimed at assessing the influence of ES product(s) on larval
migration were performed in BALB/c mice (Tsuji et al., 2003) and swine (Tsuji et al.,
2004) using the nematode Ascaris suum. Usually, pigs are infected with A. suum after
ingesting eggs containing the L2 stage. The eggs hatch in the small intestine and
penetrate the intestinal wall where the L2 to L3 molt takes place. L3s then migrate to the
liver and lungs, where they break out of the alveolar septa and are subsequently
swallowed. The L3 molts to the L4, then to the adult stage in the small intestine.
BALB/c mice and pigs were immunized with the recombinant form (rAS16) of a 16
kDa protein produced and secreted by embroyonated eggs, L3s, and adult parasites
(AS16). Antibodies produced in mice to rAS16 were used to localize native AS16 to the
hypodermis, cuticle, intestine and ovary of A. suum adult females. These antibodies also
recognized AS16 in the 48 hour ES products of infective L3s, lung stage L3s, adult
females and males. In infective and lung stage L3s, pig anti-rAS16 antibodies bound to
the esophagus, intestine, and hypodermis. The predominant antibody profile to rAS16specific antibodies in mice included IgA, IgG, and IgE. A similar response was seen in
swine. Murine IgG isotypic responses included elevated IgG1, IgG2a, and IgG3,
indicating a mixed Th1/Th2 immune response. These results were supported by
significantly higher levels of IFN-Γ, IL-2 (type I cytokines) as well as IL-10 (a type II
cytokine) in supernatants from cultures of mice splenocytes stimulated with rAS16.
Supernatants from peripheral blood mononuclear cells (PBMC) of swine displayed
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elevated IgG1 antibodies along with IL-4 and IL-10, indicating a Th2 dominant immune
response.
A reduction in larval migration was reported in both mice and pigs immunized with
rAS16. In mice, there was a 50% reduction in larval migration from the small intestine to
the lung, while 58% fewer larvae were recovered from immunized swine. In addition,
the L3 to L4 molt was inhibited in immunized swine. Furthermore, AS16 has low
similarity to mammalian proteins (Tsuji et al., 2003). This is important because the
immune responses to these proteins may limit the possibility of autoimmune reactions
(Gregory et al., 2000).
There have been multiple proteins, glycoproteins, enzymes, and enzyme inhibitors
identified in lymphatic filarial ES and known to be specifically secreted by microfilarial
and adult stages, and to a much lesser extent, infective larvae. The following four
proteins will be discussed in more detail: abundant larval transcripts (ALTs), ES-62,
acetylcholinesterases (AchE) and serine protease inhibitors (serpins).
The most notable proteins of B. malayi L3 ES are abundant larval transcript proteins –
1, and –2 (ALT-1,-2, respectively). ALT-1 is produced exclusively by L3s. ALT-2 is
also produced by L3s although lower amounts of alt-2 mRNA are present in other life
cycle stages. Although no known mammalian homologues of these proteins exist, the
two proteins are 79% identical to D. immitis abundant immunogen Di-20/22L (Frank et
al., 1995) and similar to Ov-ALT-1 and –2 in Onchocerca spp. (Joseph et al., 1998). The
lack of mammalian homologues and thus the low risk of crossreactivity with host
proteins have made the ALTs favorable targets for immunization in host protection
studies. Recombinant ALT-1 (rALT-1) is a 20kDa protein that is intensely stained in the
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L3 glandular esophagus upon hybridization with anti-Bm-rALT-1 antibody (Gregory et
al., 2000) and is secreted into its environment (Gomez-Escobar et al., 2005). Antibodies
to rALT-1 have also been observed in human sera from amicrofilaremic and
microfilaremic patients both without parasites and with subpatent infections. The
isotypic responses in these patients indicated elevated IgG1 and IgG3 with no IgG4.
Gerbils immunized with rALT-1 were found with 76% fewer parasites four weeks post
infection when compared to controls (Gregory et al., 2000).
A subsequent experiment to study the function(s) of alt-1 and -2 used alt-transfected
Leishmania mexicana in mice (Gomez-Escobar et al., 2005). Leishmania mexicana
infection is initiated when an infected sandfly bites a host and injects the infective
promastigote stage into the host. Promastigotes invade circulating macrophages,
differentiate and reproduce as amastigotes before lysing the host cell. A sandfly then
ingests amastigotes upon feeding on the host, which then differentiate into promastigotes
in the sandfly.
Murine macrophages infected with alt-transfected amastigotes contained more parasites
compared to wild-type (WT) controls at 24 hours post infection. Larger and accelerated
(8-10 weeks post infection) lesion development was also observed in mice infected with
alt-transfected amastigotes compared to infections with WT parasites (12-15 weeks post
infection). In addition, alt-transfected parasites were more resistant to IFN-Γ induced
killing by macrophages. These observations support the role of ALTs in host
immunomodulation. The Th2 associated transcripts GATA-3 and SOCS-1 were
upregulated in alt-transfected macrophages when compared to WT controls at 7 DPI.
Similar results were observed in vivo, with mice showing upregulation of the same genes
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in lymphocytes derived from the peritoneal cavity following IP infection with B. malayi
L3.
rALT-2 is a 14kDa immunogenic protein as determined by protein extracts of L3s
hybridized with sera from mice immunized with Bm-rALT-2 as well as sera from human
patients with chronic lymphatic obstruction (Ramachandran et al., 2004). Significant
reductions in viable larvae were observed in CBA mice immunized with Bm-rALT-2
(74%) following implantation of L3s in a chamber in the peritoneal cavity when
compared to PBS controls. Sera from mice immunized with the recombinant protein
indicated elevated IgG1, IgG2a, IgG2b and lower titers of IgM and IgA. Predominant
antibody responses in those immunized with an alt-2 DNA vaccine were IgG2a, IgG2b,
IgM and IgA as opposed to IgG1, unlike the response to the recombinant protein.
ES-62 is a 62kDa phosphorylcholine (PC) containing glycoprotein suggested to be
secreted by all filarial nematodes (Stepek et al., 2004) including adult stages of B.
pahangi and B. malayi (Stepek et al., 2002). ES-62 induces Th2 responses by
suppressing IL-12, IL-6, and TNF-α signaling by macrophages (Goodridge et al., 2001).
In Acanthocheilonema vitae, this glycoprotein accounts for more than 95% of all protein
released from adult parasites in vitro (Harnett et al., 1999b). In vivo secretion has also
been demonstrated, supported by its detection in the bloodstream of infected gerbils
(Harnett et al., 1990). Therefore, ES-62 has the potential to interact with cells of the
immune system (Harnett et al., 1999a). ES-62 has been shown to downregulate
lymphoproliferative responses in infected animal models by modulating signal
transduction pathways associated with the antigen receptor of B cells (Harnett and
Harnett, 2001). It has been shown that ES-62 incubated with resting splenic murine B
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cells at a concentration similar to that found in the bloodstream of parasitized humans
(Lal et al., 1987), partially prevents B cell proliferation associated with ligation of the B
cell antigen receptor. This effect is likely due to PC, as the same effect has been
demonstrated using PC conjugated to BSA as well as PC alone. These results were also
demonstrated in vivo after giving mice injections of PC-BSA or BSA alone. Cells from
mice given PC-BSA were less able to proliferate in response to antigen receptor ligation
(Harnett et al., 1999b). In addition, ES-62 is able to induce anergy to cellular activation
through the T-cell antigen receptor (Harnett et al., 1998).
Constituents of B. malayi adult and microfilarial ES, although less well described,
include acetylcholinesterases (AchEs) and serine protease inhibitors (serpins).
Acetylcholinesterases (AchEs) have been hypothesized to function in neuromuscular
transmission. These enzymes may interfere with the host immune system by degrading
acetylcholine. Acetylcholine enhances mast cell degranulation and cytotoxicity upon
activation by lymphocytes and neutrophils. Rathaur et. al., 1987 has shown a 100kDa
Brugian AchE is recognized by sera from humans with B. malayi and W. bancrofti
infections (Rathaur et al., 1987). In addition, AchE activity has been localized to
excretory and anal vesicles, and amphid and phasmid structures at the cephalic and
caudal ends of W. bancrofti microfilariae (Omar and Kuhlow, 1977). It remains unclear
whether nematode AchEs influence parasite survival, although acetylcholine may release
T cells from dependence on IL-2 for IFN-Γ production (Johnson et al., 1982).
Parasite serpins regulate a wide variety of biological functions including blood
coagulation (Cappello et al., 1995) and antigen processing (Bennett et al., 1992). A
stage-specific serpin, Bm-SPN-2, has been described in B. malayi microfilarial ES. This
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47.5 kDa protein inhibits enzymatic activity of human neutrophil cathepsin G and
neutrophil elastase (Zang et al., 1999). In addition, Bm-SPN-2 is a prominent T cell
antigen that induces an intense, but short-lived Th1 response in mice, as shown by the in
vitro production of IFN-Γ but not IL-4 or IL-5 14 DPI (Zang et al., 2000).
Additional ES constituents have been extensively studied in other nematodes.
Ancylostoma secreted proteins-1 and –2 (ASP-1, -2) are abundantly produced by L3 of
the skin-penetrating hookworms Ancylostoma caninum and Necator americanus
(NaASP-2) (Goud et al., 2005). They are cysteine-rich proteins (Hawdon et al., 1996)
belonging to the pathogenesis related (PR) protein superfamily (Asojo et al., 2005). In
order to assess the capacity of NaASP-2 to influence parasite migration, an in vitro
migration assay using hamster skin was performed (Goud et al., 2005). Infective stage
larvae were incubated with sera from rats immunized with Na-ASP-2 and Alhydrogel
adjuvant or with Alhydrogel alone and applied to hamster skin to assess the number of
larvae that were able to migrate through skin. It was shown that rat anti-NaASP-2
antibodies inhibited migration by 90 ± 7%, while Alhydrogel controls showed only 17 ±
7% inhibition.
ASP-2 has been shown to be secreted as determined by sera from rabbits immunized
with recombinant ASP-2 on western blots using 24hr. activated L3 ES (Hawdon et al.,
1999). Dogs vaccinated with ASP-2 showed elevated IgG1 and IgG2 isotypes, with
moderate IgE titers (Bethony et al., 2005). Sera from these dogs recognized ASP-2 in L3
extracts as demonstrated in western blots. The protein was immunolocalized to the
glandular esophagus of A. caninum L3s as well as the channels that connect the glandular
esophagus to the L3 surface, the cuticle and epicuticle. After percutaneous inoculation of
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L3s, a 26% reduction in gastrointestinal (GI) worm burdens were observed in vaccinated
animals relative to controls. Moreover, a 69% reduction in fecal egg counts were
recovered in vaccinated animals when compared to controls, suggesting the protein is
involved in adult worm fecundity. Using the in vitro migration assay, antibodies to
ASP-2 were shown to inhibit tissue penetration by 60% compared to control sera. This
indicates that the immune response induced by ASP-2 vaccination interferes with early
host invasion. As a result, fewer larvae would reach the GI tract resulting in reduced
numbers of adult parasites and blood loss (Bethony et al., 2005).
Several animal models have been employed to study the immunology and
pathogenesis of human filarial infections. A number have proven useful in the laboratory
including rodents, cats, dogs, ferrets, and primates infected with B. malayi or B. pahangi
(Scott, 2000). Most experimental filarial research has been performed in rodents,
specifically mice and the Mongolian gerbil using Brugia spp. inoculated subcutaneously
or intraperitoneal. Immunologically intact mice generally do not support larval
maturation past the L3 to L4 molt, but infections of nude and SCID mice do develop to
the adult stage (Babu et al., 1998).
Although all of these animal models have provided much knowledge regarding hostparasite dynamics, none of them require the larvae to pursue a more natural route of
invasion by migrating through layers of skin prior to lymphatic establishment (Porthouse
et al., 2006; Chirgwin et al., 2006) Using the permissive Mongolian gerbil, our
laboratory has developed a B. pahangi intradermal (ID) model in order to mimic a more
natural course of filarial infection (Chirgwin et al., 2006; Porthouse et al., 2006). Upon
injection of larvae ID in the hindleg, larvae can migrate away from the injection site
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within hours, with the majority leaving the site by 3 DPI. At this timepoint, the largest
number of L3 are found in the popliteal lymph node (POP), followed by the subiliac and
inguinal lymph nodes (SUB), renal lymph node (RLN), and skin and muscle surrounding
the injection site. Approximately 7 DPI the L3 molt to L4 and at approximately 28 DPI
adults are present in the lymphatics. By 60 DPI, adults have produced microfilariae that
reach the peripheral blood (Ash and Riley, 1970). Brugian infections in gerbils result in
the development of an infection by 90 DPI characterized by lymphatic lesions including
lymphatic thrombi, lymphadenitis, lymphangitis and a persistent microfilaremia (Klei et
al., 1988). Furthermmre, although B. malayi and B. pahangi both develop fully to fecund
adults, B. pahangi has attracted more attention for laboratory use because it is easier to
maintain in the laboratory. In addition, gerbils infected with B. malayi have a lower
microfilaremia when compared to infections with B. pahangi (Ash and Riley, 1970).
Nonetheless, the kinetics of lesion development and immune responses of B. pahangi and
B. malayi infections of gerbils are similar, thereby justifying the use of this nonhuman
parasite model for LF.
Though the described research using ES has identified some of its components,
detailed information regarding early L3 ES produced by B. pahangi is lacking. The aim
of this study was to assess the significance of B. pahangi L3 ES on early parasite
migration and development in Mongolian gerbils. The working hypothesis to be tested
was that proteins in Brugia spp. L3 ES are essential in early parasite migration,
development, and establishment within a permissive host, therefore antibodies to this ES
will alter the protein function and subsequently inhibit or alter early larval migration,
development, and establishment.
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Chapter 2: Brugia pahangi: Effects of Third Stage Larvae ES Immunization on
Early Migration and Parasite Establishment in Mongolian Gerbils (Meriones
unguiculatus)
2.1. Introduction
Lymphatic filariasis, caused by the filarial nematodes Brugia malayi, B. timori, and
Wuchereria bancrofti, affects approximately 128 million people in mainly tropical and
subtropical regions of the developing world and it has been estimated that 1 billion
people are at risk (Scott, 2000). These infections are initiated when an infected mosquito
feeds on a host and infective third stage larvae (L3) emerge from the mosquito proboscis
onto the skin surface in a drop of hemolymph (Ewert and Ho, 1967). The L3 then
migrates presumably into the bite wound created by the mosquito. L3 migrate through
connective tissues of the skin, into the lymphatics and subsequently to the lymph nodes
(Scott, 2000). Earlier studies by Ah and his coworkers (1973) demonstrated that vector
derived B. pahangi L3 are capable of extensive rapid migration through a variety of
tissue types. In order to quantitatively study this early migration an in vivo intradermal
inoculation model has been established using B. pahangi infections in gerbils (Chirgwin
et al., 2006; Porthouse et al., 2006). In this model, L3s are required to move through the
connective tissues of the skin prior to establishment in the lymphatics mimicking more
closely the natural early L3 migration. Although it is presumed that molecules secreted
by the L3 facilitate this migration and are involved in parasite establishment (Scott, 2000)
little is known regarding the parasite factors involved.
During this parasitic life cycle of Brugia spp., it is presumed that all stages produce
and secrete molecules into the environment (Kaushal et al., 1982; Zang et al., 2000;
Scott, 2000). These components, termed excretory/secretory products (ES) contain many
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proteins including collagenases (Petralanda et al., 1986), immunomodulaters (Harnett et
al., 1999a), and unique proteins of unknown functions (Gregory et al., 2000;
Ramachandran et al., 2004). ES has been hypothesized to function in many ways to
benefit the parasite. In Brugia spp. and other nematodes, these include aiding in parasite
migration and establishment (Sen et al., 2000; Tsuji et al., 2003; Tsuji et al., 2004), host
immune modulation (Harnett et al., 1999a) , and other unknown functions (Gregory et al.,
2000; Ramachandran et al., 2004) .
Previous studies have identified various proteins in B. malayi L3 ES including
collagenases (Petralanda et al., 1986) and perhaps most notably abundant larval transcript
proteins -1 and -2 (ALT-1, -2) (Gregory et al., 2000; Ramachandran et al., 2004). These
parasite-specific proteins have no mammalian homologues and no known function aside
from immunomodulation (Gomez-Escobar et al., 2005). The ALT proteins are L3specific and represent promising candidates for vaccine studies. Gerbils immunized with
ALT-1 harbored 76% fewer adult B. malayi in the peritoneal cavity at 4 weeks post
infection when compared to controls. Mice immunized with ALT-2 showed comparable
reductions of viable larvae at 48 hours post infection. Immunizing mice with
homologues of ALTs secreted by Onchocerca volvulus, the secreted larval acidic proteins
(SLAPs), have also produced significant protection against subcutaneous challenge (Wu
et al., 2004).
Although these previous reports have provided some knowledge concerning specific
components of ES, none of them have focused on the role of total ES on L3 migration.
The hypothesis to be tested in these studies was that ES proteins secreted by early L3s are
essential to early L3 migration and establishment and that antibody to these proteins
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would inhibit or alter this migration. A profile of all these proteins was created.
Antibody responses from ES immunized gerbils were examined.
It is shown here that an immune response, presumably antibody, to vector derived L3
ES reduces the rate of early larval migration. But, this response does not induce a
significant protection against migrating L3s or the subsequent establishment of adult
parasites. Despite these results, adult worm fecundity as measured by the production of
microfilariae and the development of granulomatous lymphatic lesions, intralymphatic
thrombi, were significantly reduced at the time of patency.
2.2. Materials and Methods
2.2.1. Parasites
Third stage B. pahangi infective larvae (L3) were collected from infected Aedes
aegypti mosquitos using techniques as previously described (Klei, et al., 1990).

In brief,

12 days following an infected blood meal, mosquitos were crushed in Roswell Park
Memorial Institute medium (RPMI) (Hyclone, Logan, UT) and L3 collected in a
Baermann apparatus.
2.2.2. Excretory/Secretory Products (ES)
Seven hundred fifty viable L3s were aliquoted into 15ml conical tubes and washed 3
times with RPMI. Final aliquots were resuspended in 2.5ml RPMI in 24 well tissue
culture plates (BD Falcon, Franklin Lakes, NJ) at a concentration of 750 L3/well. Plates
were incubated for 24 hours at 37ºC in an atmosphere of 5% CO2. The culture medium
containing ES (ES) was collected using pipets and a stereomicroscope, to ensure larvae
were not collected. Less than 10 L3 per culture were nonmotile or inviable at this time.
ES was stored at -20ºC.
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ES was thawed on ice and concentrated 100X using YM-3 Centriprep centrifugal filter
units (Millipore, Billerica MA) with a 3kDa molecular weight cutoff. ES was centrifuged
at 4ºC at 2850 X g until approximately 700µl ES in RPMI was retained. The RPMI was
exchanged with cold phosphate buffered saline (PBS) containing 1% general protease
inhibitor cocktail (Sigma, St. Louis, MO) by centrifuging as above. The ES was
collected and supplemented with an additional 1% protease inhibitor. Protein
concentration was determined by Lowry's method using the DC Protein Assay (BioRad,
La Jolla, CA). LPS activity in concentrated ES was measured using the Pyrotell Limulus
Amebocyte Lysate (LAL) assay (Associates of Cape Cod, East Falmouth, MA). The
minimum LPS concentration considered as positive for the presence of LPS was 0.25
endotoxin units/ml.
2.2.3. Animals, Experimental Design and Necropsy
Male Mongolian gerbils (Meriones unguiculatus) were purchased from Charles River
Laboratories (Wilmington, MA) at 8 weeks of age and maintained on standard rodent
chow and water ad libitum. Two in vivo experiments were conducted to test the effect of
anti-ES on early larval migration and survival (Experiment 1) and parasite maturation
within gerbils (Experiment 2). The experimental design is shown in Table 1. In both
experiments, 60 gerbils were divided into 8 groups. Four groups each containing 10
gerbils were used for infections. Four groups each containing 5 gerbils were used for
media controls. Gerbils were immunized with ES in RIBI adjuvant (Sigma) or adjuvant
alone. Gerbils in each immunization group designated for infection received multiple
injections until 95-100 B. pahangi L3s were inoculated ID within the dermis of the lower
leg or into the peritoneal cavity (IP) as previously described (Chirgwin et al., 2006;
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Table 1. Summary of Experimental Design to Test the Effects of ES Immunization on
Early Larval Migration (Experiment 1) a and Parasite Establishment (Experiment 2) b
Treatment Group

Immunization

Inoculation

Location of
Inoculation

Immunized and challenged
intradermally (ES+BP+ID)

ES in AJc

BPd

IDe

Immunized and challenged
intraperitoneally (ES+BP+IP)

ES in AJ

BP

IPf

Immunized only (ES+MC+ID)

ES in AJ

MCg

ID

Immunized Only
(ES+MC+IP)

ES in AJ

MC

IP

Control and challenged
intradermally (AJ+BP+ID)

AJh

BP

ID

Control and challenged
intraperitoneally (AJ+BP+IP)

AJ

BP

IP

Control only (AJ+MC+ID)

AJ

MC

ID

Control only (AJ+MC+IP)

AJ

MC

IP

a

Necropsies were performed in each treatment group at 3DPI
Necropsies were performed in each treatment group at 106DPI
c
ES in AJ: Gerbils were immunized with ES in RIBI adjuvant
d
BP: 95-100 Brugia pahangi L3s
e
ID: intradermal challenge
f
IP: intraperitoneal challenge
g
MC: RPMI media controls
h
AJ: Gerbils were immunized with RIBI adjuvant alone
b
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Porthouse et al., 2006). The syringe was flushed with RPMI to check for any remaining
L3. The numbers of larvae injected were recorded. The ID inoculations serve as a more
natural challenge in that L3s are required to migrate through the tissues of the skin prior
to establishment in the lymphatics. Also, the pattern of L3 migration following this
injection route has been established in gerbils (Chirgwin et. al., 2006; Porthouse et. al.,
2006). The IP inoculations, in which the majority of parasites do not migrate and remain
in the peritoneal cavity, served to determine if any anti-ES effects seen in the ID infected
groups were related only to migration. Gerbils receiving similar immunizations but
challenged with RPMI from the Baermann apparatus served as uninfected controls.
2.2.3.1. Experiment 1
In Experiment 1, necropsies were performed at 3 to 5 DPI in order to measure the
effects of anti-ES immune responses on early migration and parasite survival. Previous
studies have shown that at 3 DPI, most larvae are located in the left popliteal lymph node
following ID inoculation, indicating that larvae are actively migrating away from the
injection site (Chirgwin et al., 2006; Porthouse et al., 2006). All necropsies were not
performed 3 DPI due to time constraints. Any subsequent citations pertaining to 3-5 DPI
are termed 3 DPI for convenience.
On days 3, 24, and 71, gerbils were immunized with 50µg LPS-free ES in PBS
suspended in 300µl of 1:1 RIBI adjuvant:LPS-free physiological saline. Controls were
immunized with 300µl of 1:1 RIBI adjuvant:LPS-free physiological saline, according to
the manufacturer's protocol. Each inoculation was given in multiple intramuscular and
subcutaneous sites. Animals were bled for sera on days 0 and 86.
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Gerbils were challenged with 100L3s on day 88 either ID in the left hind limb above
the knee or 100L3 IP. Control gerbils were injected ID or IP with RPMI from the
Baermann apparatus.
At 3 DPI, all gerbils were euthanized and worm recoveries performed. The skin and
muscle at the injection site of all ID infected gerbils were removed. Muscle biopsies
were taken from the removed tissue near the injection site with a 6mm biopsy punch and
preserved in 10% formalin for histological examination. Right and left popliteal lymph
nodes (RPOP and LPOP), right and left renal lymph nodes (RRLN and LRLN), ileolumbar vessels (ILV), right and left spermatic cord lymphatics (RSPCD and LSPCD),
right and left sub-inguinal and iliac nodes (RSUB and LSUB) and right and left testes
(RTEST and LTEST) were gently teased in PBS under a stereomicroscope. Following
teasing, all tissues were left to soak for 1 hour to allow larvae to emerge. Tissues were
examined twice, with hourly soaks in between, and all visible L3s recovered.
Necropsies of gerbils with IP infections were similarly performed except the skin and
muscle were not removed from the leg. In addition, for these treatment groups, the
peritoneal cavity was washed with RPMI as well as the viscera and the carcass soaked for
1hour in PBS.
2.2.3.2. Experiment 2
The second experiment (Experiment 2) was performed to assess the role of anti-ES
immune responses on parasite establishment and lesion formation. The design,
immunization and challenge groups in this experiment were similar to those of
Experiment 1. Sera were collected on days 0 and 154. Fifteen microgram ES
immunizations and control immunizations were given on days 75, 96 and 144. Challenge
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was performed on day 157. Microfilariae were counted in 0.5ml blood at 101 DPI by the
modified Knott’s method (Chirgwin et al., 2003). Necropsies on infected animals were
performed at 106-110 DPI. All necropsies were not performed at 106 DPI due to time
constraints. Any subsequent citations pertaining to 106-110 DPI are termed 106 DPI. ID
infected animals were injected with approximately 0.1ml 1% Evan’s blue dye in saline in
each hind footpad and testes prior to necropsy to better visualize spermatic cord
intralymphatic thrombi (ILT), adult parasites, and lymphatic dilation (Klei et al., 1982).
ILT were counted in the SPCD and categorized as small, medium or large in size as
previously described (Jeffers et al., 1987). Lymphatic dilation scores ranging from 0-4
were determined for each ID infected animal (Klei et al., 1982). The criteria for scoring
was as follows: 0, no change; 1, 10-20% of the spermatic cord length of infected animals
dilated; 2, 30-50% dilation; 3, 50-80% dilation; 4, >80% dilation. Tissues were teased
for adult worms, which were subsequently sexed. In addition to the tissues examined in
Experiment 1, the heart and lungs were teased in both IP and ID infected animals. For ID
and IP infected animals, the peritoneal cavity was washed with RPMI as well as the
viscera and the carcass soaked for 1 hour in PBS.
2.2.4. CBC Analysis
For all animals in both experiments, 400µl blood was collected into EDTA tubes for
Complete Blood Counts (CBC) immediately prior to euthanasia. The total numbers of
cells were counted per microliter. Cells were stained with a modified Wright's Giemsa
stain (Hema-Tek Stain Pak; Bayer Corp., Tarrytown, N.Y.). One hundred cells were
counted and identified as neutrophils, eosinophils, basophils, monocytes, or lymphocytes.
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2.2.5. ES Characterization and Antibody Response to ES
SDS-PAGE was performed to profile ES proteins and to compare the profile with that
of somatic adult worm antigen (SAWA) and somatic B. pahangi L3 antigen (SL3A).
Protein electrophoresis was conducted using a 4-20% Tris-HCL polyacrylamide gradient
gel (Biorad) and a Mini Protean II apparatus (BioRad) as previously described (Edmonds,
2001). Eieht micrograms of ES, SAWA or 25 live B. pahangi L3s were mixed with
loading bufder and denatured as previously described (Laemmli, 1970; Edmonds, 2001).
Electrophoresis was carried out at 20 mAmp. Gels were stained with Coomassie Blue
and destained as previously described (Edmonds, 2001). Additional staining using the
ProteoSilver system (Sigma) was carried out according to the manufacturer's protocol.
Photoimaging was carried out on a FluorChem 8800 photoimager (Alpha Innotech, San
Leandro, CA ).
Preimmunized, ES immunized but prechallenge, and AJ immunized but prechallenge
sera from both experiments, pooled sera from B. pahangi infections of > 1yr (chronic)
and from infections of 35 days duration (acute) were analyzed for anti-ES antibodies
using Western blots and ELISAs. Antigens used in Western blots included ES, SAWA,
and SL3A to assess immunogenic proteins in each extract and those shared with ES. ES
and SAWA were used in ELISAs to assess the relative level and isotypic character of the
antibody response.
2.2.5.1. ELISAs
Immulon I B flat bottomed, 96 well polystyrene microwell plates (Dynex Tech.,
Chantilly, VA) were coated with 50µl ES or SAWA diluted to 15 µg/ml in coating buffer
(0.02M sodium carbonate buffer, pH 9.6). After antigen was bound overnight at 4ºC,
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antigen and coating buffer were removed and plates washed 3X for 5min with 200µl of
PBS-0.05% Tween 20 (PBST). Plates were blocked for 1.5 hours at room temperature
with 100µl of 3% fish gelatin-PBS and washed again. Primary antibody was diluted
1:100 in 1% fish gelatin-PBST (Ab buffer) and incubated in triplicates with ES or SAWA
for 1hr at 37ºC. Five pools of sera (preimmunized, ES and AJ prechallenge, chronic, and
acute infection sera) were screened against SAWA. For ES coated plates, three pools of
sera (preimmunized, chronic and aaute infection sera) and sera from 10 randomly chosen
individual samples (either ES immunized or adjuvant immunized) were used as the
primary antibody. After washing, 50µl of goat anti-mouse IgG antibody conjugated to
alkaline phosphatase (IgG-AP) (Jackson Immunoresearch, West Grove, PA), or rabbit
anti-mouse IgG1, IgG2a, IgG2b, or IgG3 -AP (Rockland, Philadelphia, PA) diluted
1:1000 in Ab buffer were added to plates and incubated 1hr at 37ºC. After washings,
100µl of BluePhos microwell phosphatase substrate was added to each well according to
the manufacturer's protocol (KPL, Gaithersburg, MD). Reactions were stopped after
20min with 100 µl of 1X BluePhos Stop Solution (KPL, Gaithersburg, MD). OD values
were read on a MRX TC Revelation ELISA reader standardized with PBST. The
minimal OD value considered accurate was either 2.5% of the coefficient of variance or
0.005 OD, whichever is greater, as determined by the manufacturer.
2.2.5.2. Western Blot Analysis
Eleven and a half micrograms of ES, SAWA, and SL3A from 80 live B. pahangi L3s
were separated using SDS-PAGE as described above. Unstained electrophoreticallyresolved proteins were transferred to nitrocellulose using a Mini Trans Blot electrode
(BioRad). Protein transfer was carried out at 25 mAmp overnight followed by 225
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mAmp for 1hour at 4ºC. Western blot hybridization was carried out as previously
described (Edmonds, 2001). In Experiment 1, all sera were diluted 1:1000 in 1% fish
gelatin-TTBS (Ab buffer). Various dilutions of sera from Experiment 2 were used.
Chronic, acute, preimmunized, and adjuvant prechallenge sera were diluted 1:250 for
each type of antigen. Anti-ES was diluted 1:1000 for ES and 1:250 for SL3A and SAWA.
IgG-AP was diluted 1:10,000 in Ab buffer and incubated for 1hr at 37ºC. Mouse reagents
were used due to a lack of suitable commercial gerbil reagents. These reagents recognize
gerbil antibodies although isotype matching of gerbil immunoglobulins remains
undescribed. Conjugates were developed with 3 ml of BCIP/NBT 1-component
phosphatase substrate (KPL, Gaithersburg, MD). Double-distilled water was used to stop
the reaction development at appropriate times. Photoimaging was carried out on a
FluorChem 8800 photoimager (Alpha Innotech).
2.2.6. Statistical Analysis
Statistical analysis was performed using SigmaStat software (Chicago, IL). When
data passed normality tests, pairwise multiple comparisons were made using the StudentNewman-Keuls (SNK) method. One Way Analysis of Variance on Ranks was used when
normality tests failed. Differences were considered statistically significant at p<0.05.
Because all infected gerbils did not receive exactly 100 L3s, total parasite recovery
means were calculated as percentages from number of larvae injected. As for
distributions and other recovery calculations, percentages from the number of parasites
recovered were calculated.
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2.3. Results
2.3.1. SDS-PAGE Gels
SDS-PAGE was used to demonstrate the protein profile of ES and compare it to that
of other parasite extracts. Some small differences in the protein profiles were observed
between ES used in Experiment 1 and ES used in the Experiment 2 (Fig 1). Fewer
distinct bands were observed in Experiment 2 ES although more bands were observed in
the lower molecular weight range. Nonetheless, the general pattern of major bands
appeared to be the same. The protein profile of SL3A and SAWA were quite different
from that of the ES used in both experiments (Fig 1).
2.3.2. ELISAs
In both experiments, a marked IgG response to ES was seen in ES immunized gerbils
and those with acute and chronic infections (Table 2). Antibody responses to ES from
immunized animals were significantly greater than in AJ immunized animals and those
with acute and chronic infections. Marked IgG1, IgG2a and IgG3 responses to ES were
seen in immunized animals indicating a mixed Th1/Th2 immune response to ES. While
greater than adjuvant controls, the responses were less in animals with both acute and
chronic infections than in those immunized with ES. The mean OD values of acute and
chronic sera suggest, like that of anti-ES, that the responses are a mixed Th1/Th2
response.
Measurable OD values to SAWA detected in ES immunized animals consisted of an
IgG and IgG1 isotypic response, especially in Experiment 2 (Table 3). The acute and
chronic responses were, as expected, greater than the ES immunized, in most instances.
Also, OD values were significantly higher in chronic than in acute infection sera. These
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Fig 1. Silver stained SDS-PAGE gel of antigens used in both experiments. Lanes show
Experiment 1 ES (ES1), Experiment 2 ES (ES2), somatic L3 antigen (SL3A), and
somatic adult worm antigen (SAWA).
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Table 2. ELISAs using ES from both experiments. Values are expressed as mean OD values ±
S.D. according to isotype from sera collected from different immunizations and infections.
Sera
IgG
Experiment 1
1.074± 0.261a
A+ES

IgG1

IgG2a

IgG2b

IgG3

0.057± 0.020 a

0.047± 0.013 a

0.026 ± 0.004 a

0.070 ± 0.016 a

Chronic

0.452 ± 0.009 b

0.028± 0.002 b

0.024 ± 0.006 b

0.020 ± 0.001 b

0.027 ± 0.002 b

Acute

0.331± 0.060c

0.038 ± 0 c

0.020 ± 0.001 b

0.025 ± 0.001 b

A

0.163 ± 0.031 d

0.017 ± 0.002 d

0.012 ± 0,004 c

0.020 ± 0.003 b

0.020 ± 0.002 c

A+ES

1.026 ± 0.283 a

0.097 ± 0.024 a

0.054 ± 0.022 a

0.011 ± 0.003 a

0.102 ± 0.050 a

Chronic

0.426 ± 0.032 b

0.073 ± 0.008 b

0.021 ± 0.001 b

0.011 ± 0.001 a

0.067 ± 0.004 b

0.006 ± 0.001 c

0.006 ± 0.0005 c

0.055 ± 0.004 c

0.005 ± 0.001* c

0.009 ± 0.002 b

0.016 ± 0.003 b

c

Experiment 2

Acute
A

0.338 ± 0.051 b

c

0.268 ± 0.075 c

b

0.034 ± 0.001 b
0.029 ± 0.004 b
0.023 ± 0.004 c

Letters indicate significance between sera type within each experiment at p<0.05. Types of
sera include that from individual animals immunized with ES in RIBI adjuvant (A + ES),
pooled sera from a chronic infection (Chronic) and from an acute infection (Acute), and from
individual animals immunized with RIBI adjuvant (A).
* Value falls below the threshold for accuracy.
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Table 3. ELISAs using SAWA from both experiments. Values are expressed as mean OD
values ± S.D. according to isotype from sera collected from different immunizations and
infections.
Sera
IgG
Experiment 1
1.062 ± 0.073 a
Chronic

IgG1

IgG2a

IgG2b

0.246 ± 0.019 a

0.021± 0.002 a

0.049 ± 0.003 a

0.056 ± 0.002 a

Acute

0.362 ± 0.017b

0.075 ± 0.005 b

0.014 ± 0.001 b c

0.021 ± 0.001 b

0.019 ± 0.001 b

ES pool

0.094 ± 0.006 c

0.024 ± 0.001 c

0.019 ± 0.005 a bc

0.014 ± 0.001 c

0.020 ± 0.001 b

AJ pool

0.040 ± 0.003 d

0.014 ± 0.002 d

0.016 ± 0.000 b

0.014 ± 0.003 c

0.024 ± 0.003 b

c

IgG3

Experiment 2
Chronic

1.062 ±0.073 a

0.246 ± 0.019 a

0.021± 0.002 a

0.049 ± 0.003 a

0.056 ±0.002 a

Acute

0.362 ± 0.017 b

0.075 ± 0.005 b

0.014 ± 0.001 b

0.021 ± 0.001 b

0.019 ±0.001 b

0.051±.001 c

-0.0003±.0005* c

-0.003 ±.001* c

0.003 ±.002* c

0.003 ± *0d

0.003 ±.004* b c

-0.003 ±.001* c

0.002 ±.001* c

ES pool
AJ pool

0.308 ±.010 c
0.078 ± 0.008 d

Letters indicate significance between sera type within each experiment at p<0.05. Types of
sera include pooled sera from a chronic infection (Chronic), from an acute infection (Acute),
from ES immunized animals (ES pool), and from adjuvant immunized animals (AJ pool).
*Values fall below the threshold for accuracy.
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responses to SAWA were dominated by IgG1.
2.3.3. Western Blots
ES used in Experiment 1 and Experiment 2, SAWA and SL3A were transferred to
nitrocellulose after separation by SDS-PAGE and hybridized with pooled prechallenge
sera from Experiment 1 and Experiment 2, pooled preimmunized sera as well as pooled
sera from gerbils with acute and chronic infections.
Some nonspecific binding of antibody to ES was observed when hybridized with all
types of sera. This is particularly distinct in bands at 62kDa and 48kDa (Fig 2).
Prechallenge sera from ES immunized animals in both experiments detected multiple
similar protein bands in homologous ES. However, there are also some differences.
Increased multiple band recognition at 27-46kDa, 9-20kDa, and <6.9kDa was observed in
ES used in Experiment 1. There were 2 bands observed in Experiment 1 ES at 53 and
97kDa not visible in Experiment 2 ES. In both experiments, anti-ES recognized heavy
bands at 14kDa and 20kDa, suggesting the presence of antibody to abundant larval
transcript proteins 1 and 2 (ALT-1, -2) respectively (Gregory et al., 2000; Ramachandran
et al., 2004). Some bands detected in ES with prechallenge sera were also recognized
weakly by acute and chronic infection sera.
In ES used in Experiment 2, chronic sera recognized bands in predominantly lower
molecular weight ranges between <6.9kDa to 110 kDa (Fig 2). Fewer bands were
observed in ES from the same experiment when hybridized with acute infection sera.
Identical reactions were seen using control sera (adjuvant and preimmunized sera)
hybridized to both Experiment 1 and Experiment 2 ES. Therefore, one blot using each
type of sera is shown.
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Fig 2. Western blots using ES used in Experiments 1(A1, B1, C1, D1, & E1) and 2 (A2,
B2, & C2). Blots were hybridized with various pooled sera including anti-ES
prechallenge sera from Experiment 1 (A1) and Experiment 2 (A2), acute infection sera
(B1, B2), chronic infection sera (C1, C2), adjuvant sera (D1), and preimmunized sera
(E1).
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The same 62kDa nonspecific band was present in SAWA and in ES on all membranes
(Fig 3, 4). As expected, acute and chronic sera recognized different proteins in both
SAWA and SL3A. In SAWA hybridized with acute infection sera, bands recognized
were in the lower molecular weight region as opposed to those recognized by chronic
infection sera. In SL3A, nonspecific reactions were not seen with any sera (Fig 4). AntiES, acute, and chronic infection sera recognized a 14kDa band, perhaps indicating the
presence of ALT-2 (Ramachandran et al., 2004).
2.3.4. Hematology
Complete Blood Counts (CBCs) were employed to determine the role of ES
immunization on leukocyte production following challenge. The total numbers and types
of leukocytes were enumerated for each treatment group. Differences between groups
were not seen for either total leukocytes or any cell type enumerated in Experiment 1.
However, a trend was noticed with higher basophil and eosinophil numbers in infected
animals irrespective of their immunizations (ES+BP+ID, ES+BP+IP, AJ+BP+ID,
AJ+BP+IP) (see appendix-Table A). In Experiment 2, circulating leukocytes were
compared as in Experiment 1. Although not significant, higher numbers of eosinophils
were seen in all infected animals as in Experiment 1 compared to media controls (see
appendix-Table B). Significantly more eosinophils were found in ES+BP+IP animals
when compared to ES+MC+IP animals.
2.3.5. Experiment 1 Worm Recoveries
Total L3 recoveries were significantly greater in animals immunized with ES and
challenged ID (ES+BP+ID) as compared to ID controls which were immunized only with

29

Fig 3. Western blots using somatic adult worm antigen (SAWA) and sera from both
experiments. Blots were hybridized with anti-ES prechallenge sera from Experiment 1
(A1) and 2 (A2), acute infection sera (B1), chronic infection sera (C1), adjuvant sera
from Experiment 1 (D1), and preimmunized sera from Experiment 1 (E1).
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Fig 4. Western blots using somatic L3 antigen (SL3A) and sera from both experiments.
Blots were hybridized with anti-ES prechallenge sera from Experiment 1 (A1) and 2
(A2), acute infection sera (B1), chronic infection sera (C1), adjuvant sera from
Experiment 1 (D1), and preimmunized sera from Experiment 1 (E1).
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adjuvant (AJ+BP+ID) (Fig 5). Although not significant, greater numbers of L3s were
also found in ES immunized animals challenged IP (ES+BP+IP) as compared to IP
controls (AJ+BP+IP). Recoveries were significantly higher in IP infected animals of
both treatment groups (ES+BP+IP, AJ+BP+IP) when compared to ID inoculated animals
(ES+BP+ID, AJ+BP+ID).
In both ID groups (ES+BP+ID, AJ+BP+ID), the total percent recovery of L3s from
different sites showed that a majority of larvae migrated away from the injection site of
the left leg by 3 DPI (Fig 6). Most of these larvae were located on the left side of the
animals’ bodies in both treatment groups. At 3 DPI, tissues that harbored the most larvae
in ES immunized and ID challenged animals (ES+BP+ID) were the LPOP, ILV, skin,
and muscle. In the ID controls (AJ+BP+ID), the larvae were found in higher numbers in
the LPOP, LRLN, muscle, LSUB and LSPCD. Significantly more larvae were recovered
from LSUB in AJ + BP + ID animals and from the ILV in ES + BP + ID animals.
Larval recoveries from different tissues following ID challenge (ES+BP+ID,
AJ+BP+ID) were also calculated according to proximity to the intradermal challenge site
(Fig 7). Necropsy sites proximal to the site included the skin and muscle surrounding the
site and LPOP which is the initial lymph node that filters lymph from the challenge site.
Other lymphatic sites considered distal to the injection site included RRLN, LRLN,
RSUB, LSUB, RSPCD, LSPCD, RTEST, and LTEST. The RPOP was not considered
since no larvae were recovered in this location in either treatment group. In addition, the
ILV was not considered due to ambiguity as to whether its location is proximal or distal
to the challenge site. As expected, based on previous observations (Chirgwin et al., 2006;
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Fig 5. Mean larval recoveries by treatment group in Experiment 1. Animals were
immunized with either ES in RIBI adjuvant (ES immunized) or with RIBI adjuvant alone
(AJ immunized). Animals were challenged ID or IP. Three DPI, larvae were recovered
and reported as mean percent recoveries. Letters indicate significance (p<0.05) between
experimental and control groups within and between each type of challenge.
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Fig 6. Mean larval recoveries from ES immunized animals challenged ID (ES+BP+ID)
and AJ immunized animals challenged ID (AJ+BP+ID) from specific sites following ID
challenge in Experiment 1. Sites included the skin and muscle surrounding the injection
site. Lymph nodes examined were the left popliteal (LPOP), left and right subiliac and
inguinal (LSUB and RSUB), and left and right renal (LRLN and RRLN) nodes. Other
lymphatic sites included the left and right spermatic cord (LSPCD and RSPCD), ileolumbar vessels (ILV), and the left and right testes (LTEST and RTEST). The RPOP was
not included because no larvae were found in this site in either immunization group.
Letters indicate significance between treatment groups within each necropsy site
(p<0.05).
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Fig 7. Mean larval recovery percentages according to proximity to injection site in ES
immunized animals challenged ID (ES + BP + ID) and AJ immunized animals challenged
ID (AJ + BP + ID) in Experiment 1. Proximal necropsy sites include skin, muscle, and
LPOP. Distal sites are RRLN, LRLN, RSUB, LSUB, RSPCD, LSPCD, RTEST, and
LTEST. Letters indicate significance (p<0.05) between experimental and control groups
within each site grouping as well as between groupings.
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Porthouse et al., 2006) in both treatment groups, the majority of larvae were found
proximal to the challenge site at 3 DPI (Fig 7). However, there was a significantly
greater percentage of larvae recovered proximally in ES immunized animals challenged
ID (ES+BP+ID) compared to ID controls (AJ+BP+ID). Conversely, in ID controls
(AJ+BP+ID), significantly more larvae were recovered distally to the injection site.
These results indicate that immunization with ES limits L3 migration and suggests that
ES may facilitate early larval migration through host tissues.
IP challenged animals were analyzed according to larval presence in the peritoneal
cavity compared to other tissues outside the peritoneal cavity. The majority of larvae in
both treatment groups were confined to the peritoneal cavity with 97.8 ± 2.1% in ES
immunized animals challenged IP (ES+BP+IP) and 94.3 ± 5.7% in IP controls
(AJ+BP+IP) (see appendix-Fig. A).
No cell infiltration was observed in the histological sections.
2.3.6. Experiment 2 Worm Recoveries
A similar number of adult parasites were recovered in ID challenged animals in both
treatment groups (ES+BP+ID, AJ+BP+ID) (Fig 8). As for IP infected animals, 19%
fewer adult parasites were recovered in ES immunized animals (ES+BP+IP) compared to
controls (AJ+BP+IP).
The majority of adult parasites recovered were located in the heart and lungs, SPCDs,
and ILV of both ID infected groups (ES+BP+ID, AJ+BP+ID) (Fig 9). A preponderance
of worms was recovered on the right side of the body (RPOP, RSUB, RRLN, and
RSPCD) in ES+BP+ID gerbils. Furthermore, increased worm recoveries from
AJ+BP+ID controls were noted on the left side of the body (LPOP, LSUB, LSPCD, and
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Fig 8. Mean adult parasite recoveries by treatment group for Experiment 2. Animals
were immunized with either ES in RIBI adjuvant (ES immunized) or with RIBI adjuvant
alone (AJ immunized). Animals were challenged ID or IP with B. pahangi L3s. At 106
DPI, adult parasites were recovered and reported as mean percent recoveries. Error bars
represent SEM.
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Fig 9. Mean adult parasite recoveries from specific tissues following ID challenge in
Experiment 2. Animals were immunized with ES in RIBI adjuvant and challenged ID
with B. pahangi L3s (ES + BP + ID) or with RIBI adjuvant alone and challenged
similarly (AJ + BP + ID). At 106 DPI, adult parasites were recovered and reported as
mean percent recoveries. Sites examined included lymph nodes: left and right popliteal
(LPOP and RPOP), left and right subiliac and inguinal (LSUB and RSUB), and left and
right renal (LRLN and RRLN) nodes. Other lymphatic sites included the left and right
spermatic cord (LSPCD and RSPCD), ileo-lumbar vessels (ILV), and the left and right
testes (LTEST and RTEST). Non-lymphatic sites were the heart and lungs and the
peritoneal cavity (Per Cavity). Letters indicate significance (p<0.05) between
experimental and control groups within each necropsy site. Error bars represent SEM.
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LTEST). The only significant difference was observed in the LTEST. Because of these
trends, the mean numbers of parasites for each treatment were grouped according to the
right and left side of the gerbil body (Fig 10). Significantly more parasites were
recovered on the left side compared to the right side in AJ+BP+ID controls as expected.
The difference between recoveries of the left vs right sides in ES+BP+ID animals is
much less pronounced although more adults were recovered on the right side of the body.
As in Experiment 1, we examined the mean percent recoveries according to proximity
to the intradermal injection site. The only proximal site examined in this experiment was
the LPOP. Distal sites were identical to those examined in Experiment 1. For each ID
treatment group (ES+BP+ID, AJ+BP+ID), significantly fewer parasites were recovered
proximally (1.2 ± 2.7) (see appendix-Fig. B). Most were located in distal sites (92.1 ±
21.1). No differences were observed between treatment groups.
Like Experiment 1, most parasites were confined to the peritoneal cavity in IP infected
gerbils with very few migrating to other tissues (see appendix-Fig. C). The majority of
larvae were confined to the peritoneal cavity with 87.31 ± 12.9 in ES immunized animals
(ES+BP+IP) and 89.81 ± 14.3 in AJ immunized animals (AJ+BP+IP).
2.3.7. Experiment 2 ILT
The role of ES immunization on the development of ILT was examined. There were
significantly more ILT produced per parasite in AJ+BP+ID control animals compared to
ES+BP+ID animals (Fig 11). In order of frequency of occurrence, small, medium, and
large sized ILT were observed for both treatment groups. No differences were detected
in degree of lymphatic dilation between treatment groups.
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Fig 10. Mean numbers of adult parasites recovered in Experiment 2 when the gerbil body
is divided sagitally. Animals were immunized with ES in RIBI adjuvant and challenged
ID with B. pahangi L3s (ES + BP + ID) or with RIBI adjuvant alone and challenged
similarly (AJ + BP + ID). Tissues located on the left side of the body include LPOP,
LRLN, LSUB, LTEST, and LSPCD. Tissues on the right side include RPOP, RRLN,
RSUB, RTEST, and RSPCD. Letters indicate significance (p<0.05) between the left and
right sides of the body within each treatment group. Error bars represent SEM.
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Fig 11. Total intralymphatic thrombi (ILT) produced per worm in the SPCDs in
Experiment 2. Animals were immunized with either ES in RIBI adjuvant and challenged
ID with B. pahangi L3s (ES + BP + ID) or RIBI adjuvant alone and challenged similarly
(AJ + BP + ID). At 106 DPI, adult parasites and ILT were counted in the SPCD
lymphatics. Letters indicate significance (p<0.05) between experimental and control
groups. Error bars represent SEM.
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2.3.8. Experiment 2 Microfilaremia
Although there were no differences in the total numbers of microfilariae between
treatment groups, more microfilariae were noticed in AJ+BP+ID (413 ± 430) and
AJ+BP+IP (110 ± 218) controls when compared to ES+BP+ID (172 ± 314) and
ES+BP+IP (57 ± 115) groups (see appendix-Fig. D). But, significantly more
microfilariae produced per female parasite recovered were noticed in AJ+BP+ID controls
(20.17 ± 17.37) compared to ES+BP+ID animals (9.64 ± 14.12) (Fig 12).
2.4. Discussion
ES is likely to serve multiple vital roles in the early migration and establishment of
tissue migrating nematode L3s. These include but are not limited to, aiding in parasite
migration (Ghosh and Hotez, 1999; Tsuji et al., 2003; Tsuji et al., 2004; Bethony et al.,
2005), immunomodulation perhaps by modulating cytokine signaling (Gomez-Escobar et
al., 2005), and/or suppressing B and T cell proliferation (Harnett and Harnett, 1993).
Anti-ES immunity has been demonstrated to be protective in animals with other
nematode infections (Gregory et al., 2000; Tsuji et al., 2003; Tsuji et al., 2004; Bethony
et al., 2005). Antibody to ES has also been demonstrated to inhibit migration of Necator
americanus L3 through hamster skin in vitro (Goud et al., 2005). Therefore, functional
inhibition of essential components in ES by antibody can be expected to alter the
outcome of infection. This experiment was designed to test this hypothesis by
immunizing gerbils with ES followed by ID challenge with infective B. pahangi larvae.
The ID inoculation model has been characterized in the gerbil, a permissive laboratory
host (Chirgwin et al., 2006; Porthouse et al., 2006). This system allows for the in vivo
investigations of factors important to the early migration and establishment of lymphatic
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Fig 12. Mean numbers of microfilariae (MFs) produced per female adult recovered in
Experiment 2. Animals were immunized with either ES in RIBI adjuvant and challenged
ID with B. pahangi L3s (ES + BP + ID) or with RIBI adjuvant alone and challenged
similarly (AJ + BP + ID). At 101 DPI, 500µl blood was collected and microfilariae were
counted. Letters indicate significance (p<0.05) between experimental and control groups.
Error bars represent SEM.
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infections. The effects of anti-ES on tissue migration and early establishment were
detected by performing necropsies at 3 days following ID inoculations. Necropsies at a
later time measured the significance of L3 ES on later migrations and development of a
patent infection. Any effects of the immunizations on IP infections could be related to
inhibitions of parasite factors not important to tissue migration.
Some differences in the protein profiles of the ES used in Experiment 1 and
Experiment 2 were seen in silver stained SDS-PAGE gels and differential band
recognition by acute and chronic sera. Nonetheless, ES immunized gerbils in both
experiments were shown to produce a strong, mixed Th1/Th2 antibody response to
multiple similar proteins in ES at the time of challenge. In spite of the presence of these
antibodies, no significant worm reductions were noted in immunized gerbils challenged
either ID or IP in either experiment, indicating that the induced immune response and
these antibodies to multiple ES proteins do not provide protection.
The lack of protection observed is unlike that shown in previous experiments using ES
components such as abundant larval transcripts (ALT-1, and 2) and other secreted
proteins (Ghosh and Hotez, 1999; Gregory et al., 2000; Sen et al., 2000; Tsuji et al.,
2003; Tsuji et al., 2004; Ramachandran et al., 2004; Bethony et al., 2005). B. malayi L3s
produce and secrete ALT-1 and –2. ALT-1 immunized gerbils have been shown to
harbor reduced parasite burdens (76%) when challenged IP (Gregory et al., 2000).
Similarly, ALT-2 immunization reduced viable parasite loads by 74% in mice implanted
with a chamber containing L3s (Ramachandran et al., 2004). Although the presence of
ALT proteins in the ES used in the current experiments was not confirmed with known
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antibody, heavy protein bands of similar sizes to the ALTs (14kDa and 20kDa) were
demonstrated in the ES used in Experiments 1 and 2.
The reasons for the lack of protection induced by ES in the current experiments are
unknown. In previous studies (Ghosh and Hotez, 1999; Gregory et al., 2000; Sen et al.,
2000; Tsuji et al., 2003; Tsuji et al., 2004; Ramachandran et al., 2004; Bethony et al.,
2005), protection was dependent upon immunizing animal hosts with a single
recombinant ES protein. Challenges occurred in mice orally (Ghosh and Hotez, 1999;
Sen et al., 2000; Tsuji et al., 2003) or by chamber implantation (Ramachandran et al.,
2004), in pigs orally (Tsuji et al., 2004), in dogs percutaneously (Bethony et al., 2005), or
in gerbils IP (Gregory et al., 2000). In the current study, a mixture of unknown ES
proteins was used for the immunizations and challenges were performed using both the
IP and ID routes of innoculation. It is possible, although unlikely, that ALT proteins were
not present in the ES preparations used in the current experiments. It is also possible that
these proteins were present but altered during the collection process destroying the
relevant epitopes required for protection. Alternatively, other proteins present in the ES
could have interfered with the protection induced by ALTs on their own. By inducing an
antagonistic immune response that negated the protective response provided by ALTinduction, a protective response may not have been initiated (Abraham et al., 2001).
It is also possible that the larvae migrate too quickly from the injection site to the
lymphatics for any protective response to have an effect on the tissue migration process.
Anti-ES immunity may minimize the down regulatory effect on protective responses, but
the response could have an effect later on. If this is true, then antibody-mediated
neutralization of the ES produced by the migrating larvae may not be initiated in time for
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effective protection at this stage. In addition, a cellular response may also be limited, if
an antibody-dependent cell mediated cytotoxicity mechanism is involved in protection.
Alternatively, protection may be based on a different mechanism of cellular response and
it is possible that the immunization protocol did not induce the appropriate cellular
immune response required for protection. This seems unlikely as cellular responses are
necessary to induce the antibody responses, which were demonstrated in immunized
gerbils. Therefore, it is logical to assume that the immunization must have produced a
strong cellular response. Finally, it must be considered that even if sufficient immune
responses were produced to ES, protection against migrating L3 may not be central to
protection in this system. In this regard it is important to note that protection was also not
seen in IP infected animals, in contrast to what has been previously reported using ALT
in this model system (Gregory et al., 2000).
Although no significant protection was observed in either experiment, it is interesting
to note that larval recoveries in Experiment 1 were actually increased in immunized
animals, particularly in the ID infected individuals. This may be due to decreased larval
migration, facilitating the recovery of L3 that concentrated in the area around the
injection site. In control animals, the larvae were more scattered and therefore more
difficult to recover. It is known that larvae also migrate to tissues other than those
examined at necropsy, such as the heart and lungs (Ah and Thompson, 1973). Since
larvae in control animals migrated faster than in immunized animals, it is possible that
more larvae migrated to those tissues not examined at necropsy.
While protection was not observed in immunized animals, alterations in migration
patterns were seen in ID infected individuals. Since Brugia spp. requires extensive tissue
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migration prior to parasite establishment, it is probable that proteins involved in
processes such as tissue destruction are produced and secreted by invading L3s (Scott,
2000). ES components of other nematodes have been implicated in migration of larvae in
vitro including B. malayi (Petralanda et al., 1986) and Strongyloides stercoralis
(McKeprow et al., 1990) and in vivo including A. suum (Tsuji et al., 2003; Tsuji et al.,
2004) and A. caninum (Sen et al., 2000; Bethony et al., 2005). In vitro studies with S.
stercoralis and B. malayi L3 secretions have isolated metalloproteases with collagenase
(Petralanda et al., 1986; Williamson et al., 2006) and elastase (McKerrow et al., 1990)
activities. It is known that these larvae must past through the collagen and elastincontaining extracellular matrix of connective tissue prior to establishment. In an in vitro
assay, an L3-secreted metalloprotease with elastase activity of S. stercoralis was able to
degrade a model of the dermal extracellular matrix of connective tissue. Similarly,
collagenase activity was detected in L3 secretions of B. malayi, which was shown to
degrade collagen fibrils in vitro. In addition, the collagenase described shares antigenic
epitopes with that of a bacterial collagenase of Clostridium histolyticum. Sera from
human patients infected with Brugian filariasis recognized the C. histolyticum
collagenase as a 97kDa protein on Western blots. This is the same molecular weight of
an immunogenic protein found in ES used in Experiment 2 when hybridized with anti-ES
(Fig 2). Although not visualized in Experiment 1 ES, the 97kDa protein may still be
present but at lower concentrations. It is possible that antibody-mediated neutralization
of this protein could partially explain the reduced migration rates found in immunized
animals at 3 DPI.

47

In vivo demonstration of proteins involved in larval migration include those produced
by A. suum (Tsuji et al., 2003; Tsuji et al., 2004) and A. caninum (Sen et al., 2000;
Bethony et al., 2005). Mice and swine immunized with a protein secreted by A. suum
L3s (rAS16) show significant reductions in larval migration from the small intestine to
the lung. In A. caninum ES, abundant secreted proteins-1 and –2 (ASP-1, -2) were also
shown to reduce larval migrations in a similar manner.
A decrease in fecundity of B. pahangi adults was noted in ES immunized animals in
Experiment 2. The levels of circulating microfilariae were lower in immunized gerbils
challenged ID and IP although this reduction was not significant. More importantly,
significantly fewer microfilariae were produced per female worm recovered following ID
infections.
Immunizations with ES proteins have been demonstrated to reduce female nematode
fecundity in other host parasite systems. Dogs immunized with ASP proteins show
reduced adult worm fecundity as determined by a reduction in egg shedding (Bethony et
al., 2005). Similarly, significant reductions in parasite fecundity can also be seen in
hamsters immunized with ASP-2 produced by Ancylostoma ceylanicum (Mendez et al.,
2005). Cathepsin-L cysteine proteases (CPLs) have been identified in the ES of B.
malayi and B. pahangi L3s. These proteases have been implicated in eggshell
remodeling (Guiliano et al., 2004). It is plausible that antibodies to CPLs may inhibit
production of microfilariae as in Experiment 2.
A reduction in the granulomatous response, numbers of ILT, was seen in ES
immunized gerbils in Experiment 2. This may be due to the lower numbers of
microfilariae in the SPCD lymphatics in these treatment groups. It is known that
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microfilariae contribute to ILT formation. This is evident from previous experiments
where microfilariae were found in the nidus of ILT in microfilaremic gerbils (Vincent et.
al., 1980; Jeffers et al., 1987). It is logical to assume that if there are more microfilariae
in the SPCD, then more ILT will be formed, while fewer microfilariae will result in fewer
ILT. It is also known that presensitizing naive gerbils with somatic microfilarial antigen
will induce an immune response to subsequent challenge, resulting in a decreased
microfilaremia (Klei et. al., 1982). This decreased microfilaremia could be due to the
response induced by presensitization either decreasing the fecundity of adults or
increasing the killing of microfilariae. Both of these scenarios would result in a decrease
in the numbers of circulating microfilariae. However, ILT formation was actually
increased in presensitized gerbils, suggesting the decreased microfilaremia was probably
due to the increased killing of circulating microfilariae rather than reducing fecundity.
This increase in ILT indicates that at one time, there were higher numbers of
microfilariae that were subsequently killed by the immune response induced by the
presensitization, thereby creating more ILT in which microfilariae consisted of the nidus.
In the present study, ES immunization decreased the numbers of total circulating
microfilariae, as well as the numbers of microfilariae produced per female. Also, ILT
formation was decreased, unlike the presensitization study. As a result, the reduction in
ILT formation may be due to the decreased levels of circulating microfilariae observed as
a result of the decreased fecundity of adult worms. Therefore, it is likely that proteins in
L3 ES are involved in microfilarial production and subsequent ILT formation. If this is
the case, then the immune response to ES is able to inhibit these mechanisms.
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In conclusion, parasite secretions have become some of the most intensively studied
molecules, showing a strong association with larval invasion and host parasitism.
Although it appears that antibodies to L3 ES are not sufficient to induce protection in
gerbils infected ID, they are capable of recognition by the immune response. However
the immune response to ES has been shown to reduce early migration rates, parasite
fecundity, and lymphatic lesion formation. It is now important to analyze the biological
functions of these ES products in the host-parasite interaction in order to develop a
clearer picture of how these products function in a host.

50

Chapter 3: Conclusions
In order to study the significance of Brugia pahangi L3 ES on parasite migration and
establishment, two in vivo investigations using Mongolian gerbils were conducted. These
were carried out using an intradermal infection model previously established (Porthouse
et al., 2006; Chirgwin et al., 2006). There were some differences detected between the
two preparations of ES used. This is most evident in silver stained SDS-PAGE gels and
in the Western blots using acute and chronic sera hybridized to ES used in both
experiments. In spite of these minor differences, antibodies produced to both
preparations did not induce significant protection in either experiment. These results in
some ways contradict previous studies which used recombinant Brugia malayi ES
proteins (Gregory et al., 2000; Ramachandran et al., 2004). Our studies suggest that the
gerbil immune responses to L3 ES are not sufficient to induce a host protection.
Nonetheless, L3 ES is still able to induce a potent Th1/Th2 immune response to multiple
ES proteins.
However, ES immunization does reduce early migration rates like that seen in other
systems such as A. suum in pigs (Tsuji et al., 2004) and mice (Tsuji et al., 2003) and A.
caninum in mice (Sen et al., 2000; Bethony et al., 2005). Furthermore, the final location
of adult worms in ES immunized animals was significantly different from AJ immunized
animals, supporting the effect of anti-ES immunity on migration after 3 DPI. A decrease
in microfilarial production was also seen in ES immunized animals and has been
previously shown using A. caninum (Bethony et al., 2005) and A. ceylanicum (Mendez et
al., 2005). There are perhaps proteins in L3 ES also involved in microfilariae production.
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In addition, lymphatic lesion (intralymphatic thrombi) development was also decreased
probably as a result of the decrease in SPCD microfilariae.
The resulting study contributes to the growing field of research on nematode secretions
and their effects on the host during infection. Fupther molecular studies of Brugia spp.
L3 ES are needed to determine the function(s) of these secreted proteins. By
accomplishing this, a wide variety of vaccine candidates may emerge.
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Table A. Experiment 1 Total Cells and Cell Types in Complete Blood Counts (CBC) (X 10^3/µl). Values are expressed
as mean values ± S.D. according to type of leukocyte from different immunizations and infections.
Treatment
Group

Total Cells
(*10^3/µl)

ES + BP + ID
AJ + BP + ID
ES + MC + ID
AJ + MC + ID
ES + BP + IP
AJ + BP + IP
ES + MC + IP
AJ + MC + IP

16.25 ± 3.74
17.01 ± 4.24
17.80 ± 8.57
15.34 ± 3.21
16.61 ± 4.66
12.55 ± 2.91 a
15.98 ± 2.57
17.74 ± 3.95 b

Total
Lymphocytes
(*10^3/µl)
12.22± 3.55
11.78 ± 3.64
10.66 ± 4.20
11.97 ± 2.02
12.45 ± 3.47
10.06 ± 2.56
12.65 ± 2.97
13.41 ± 2.00

Total
Neutrophils
(*10^3/µl)
3.82 ± 1.84
4.87 ± 2.44
7.05 ± 5.17
3.16 ± 1.50
3.73 ± 2.42
2.28 ± 1.24
3.16 ± 1.25
4.16 ± 2.76

Total
Eosinophils
(*10^3/µl)
0.13 ± 0.14
0.22 ± 0.17
0.04 ± 0.07
0.08 ± 0.07
0.34 ±0.34
0.12 ± 0.10
0.19 ± 0.16
0.05 ± 0.08

Total
Basophils
(*10^3/µl)
0.03 ± 0.06
0.10 ± 0.15
0
0
0.05 ± 0.07
0.03 ± 0.05
0
0

Total
Monocytes
(*10^3/µl)
0.02 ± 0.06
0.01 ± 0.04
0.04 ± 0.07
0.12 ± 0.12
0.02 ±0.06
0.06 ± 0.08
0.03 ± 0.06
0.11± 0.15

Animals were immunized with: ES and challenged ID with B. pahangi L3s (ES+BP+ID), RIBI adjuvant and challenged ID
with B. pahangi L3s (AJ+BP+ID), ES and challenged ID with RPMI (ES+MC+ID), RIBI adjuvant and challenged ID with
RPMI (AJ+MC+ID), ES and challenged IP with B. pahangi L3s (ES+BP+IP), RIBI adjuvant and challenged IP with B.
pahangi L3s (AJ+BP+IP), ES and challenged IP with RPMI (ES+MC+IP), or RIBI adjuvant and challenged IP with RPMI
(AJ+MC+IP).
a, b
Letters indicate significance at p < 0.05 within cell type between experimental and control
groups
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Table B. Experiment 2 Total Cells and Cell Types in Complete Blood Counts (CBC) (X 10^3/µl). Values are expressed
as mean values ± S.D. according to type of leukocyte from different immunizations and infections.

ES + BP + ID

Total
Total
Lymphocytes Neutrophils
(*10^3/µl)
(*10^3/µl)
14.24 ± 1.26 10.41 ± 3.11 3.47 ± 1.32

Total
Eosinophils
(*10^3/µl)
0.26 ± 0.24

Total
Basophils
(*10^3/µl)
0.028 ± 0.06

Total
Monocytes
(*10^3/µl)
0.057 ± 0.10

AJ + BP + ID
ES + MC + ID
AJ + MC + ID
ES + BP + IP

13.43 ± 1.65 10.47 ± 4.88
17.48 ± 0.99 12.18 ± 2.51
16.03 ± 2.30 10.22 ± 3.28
18.57 ± 1.69 12.4 ± 2.98

3 ± 1.29
4.98 ± 2.21
2.68 ± 0.70
5.6 ± 3.15

0.4 ± 0.31
0.098 ± 0.15
0.26 ± 0.22
0.37 ± 0.18 a

0.03 ± 0.06
0.105 ± 0.24
0.062 ± 0.12

0.102 ± 0.12
0.105 ± 0.24
0.031 ± 0.06

AJ + BP + IP 16.21 ± 1.13 12.48 ± 3.58
ES + MC + IP 15.88 ± 2.76 11.78 ± 3.97
AJ + MC + IP 14.06 ± 1.49 10.54 ± 1.96

3.33 ± 2.17
3.48 ± 2.14
3.13 ± 1.91

0.374 ± 0.30
0.152 ± 0.13 b
0.237 ± 0.18

0.082 ± 0.14
0.042 ± 0.07
0.198 ± 0.19
0.081 ± 0.13

0.087 ± 0.13
0.0483 ± 0.11
0.258 ± 0.17
0.061 ± 0.09

Treatment
Group

Total Cells
(*10^3/µl)

Animals were immunized with: ES and challenged ID with B. pahangi L3s (ES+BP+ID), RIBI adjuvant and challenged ID
with B. pahangi L3s (AJ+BP+ID), ES and challenged ID with RPMI (ES+MC+ID), RIBI adjuvant and challenged ID with
RPMI (AJ+MC+ID), ES and challenged IP with B. pahangi L3s (ES+BP+IP), RIBI adjuvant and challenged IP with B.
pahangi L3s (AJ+BP+IP), ES and challenged IP with RPMI (ES+MC+IP), or RIBI adjuvant and challenged IP with RPMI
(AJ+MC+IP).
a, b
Letters indicate significance at p < 0.05 within cell type between experimental and control groups
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Fig. A. Mean larval recoveries in the peritoneal cavity (peritoneal cavity wash, viscera,
and body soak) and in other sites (all other tissues) in Experiment 1. Animals were
immunized with either ES in RIBI adjuvant and challenged IP (ES + BP + IP) or with
RIBI adjuvant alone and challenged similarly (AJ + BP + IP). Three DPI, larvae were
recovered and reported as mean percent recoveries. Letters indicate significance
(p<0.05) between experimental and control groups within and between each necropsy
site.
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Fig B. Mean adult recovery percentages according to proximity to injection site in ES +
BP + ID and AJ + BP + ID animals in Experiment 2. The only proximal site examined
was the LPOP. Distal sites are RPOP, RRLN, LRLN, RSUB, LSUB, RSPCD, LSPCD,
RTEST, and LTEST. Letters indicate significance (p<0.05) between experimental and
control groups within each site grouping as well as between groupings.
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Fig C. Mean adult recoveries in the peritoneal cavity (peritoneal cavity wash, viscera, and
body soak), other sites (all other tissues except heart and lungs), and heart and lungs in
Experiment 2. Animals were immunized with either ES in RIBI adjuvant and challenged
IP (ES + BP + IP) or with RIBI adjuvant alone and challenged similarly (AJ + BP + IP).
At 106 DPI, adults were recovered and reported as mean percent recoveries. Letters
indicate significance (p<0.05) between experimental and control groups within and
between each necropsy site.
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Fig D. Mean numbers of microfilariae in ES immunized or AJ immunized animals
challenged ID or IP at 101 DPI in Experiment 2. A Knotts test was performed using
500µl blood. Error bars represent SEM.
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